Microlet Lancets

Microlet lancets are essential medical tools used for blood glucose testing, originally developed by the German pharmaceutical giant Bayer as part of their diabetes care portfolio. The brand's history is rooted in Germany's advanced medical engineering sector. In 2016, Bayer sold its Diabetes Care business to Panasonic Healthcare Holdings, leading to the creation of Ascensia Diabetes Care. Today, Ascensia is owned by PHC Holdings Corporation, based in Tokyo, Japan.

While the brand has its origins in Germany and is managed through Switzerland by Ascensia Diabetes Care Holding AG, the manufacturing of these specific lancets takes place in Poland, as indicated on the packaging. This global supply chain combines German design heritage with Japanese corporate ownership and European manufacturing, ensuring that high-quality medical supplies are distributed globally to support individuals with diabetes.